Abacus Life (NASDAQ:ABL - Get Free Report) is expected to be announcing its Q2 2025 earnings results after the market closes on Thursday, August 7th. Analysts expect Abacus Life to post earnings of $0.17 per share and revenue of $43.38 million for the quarter.
Abacus Life (NASDAQ:ABL - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.16 by $0.02. The firm had revenue of $44.14 million during the quarter, compared to analyst estimates of $39.51 million. Abacus Life had a negative net margin of 13.35% and a positive return on equity of 16.76%. On average, analysts expect Abacus Life to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Abacus Life Stock Down 2.2%
Shares of NASDAQ:ABL traded down $0.12 during midday trading on Friday, hitting $5.29. 799,119 shares of the company's stock traded hands, compared to its average volume of 606,371. The company has a market cap of $512.34 million, a PE ratio of 7.51 and a beta of 0.01. Abacus Life has a twelve month low of $4.60 and a twelve month high of $11.86. The firm's fifty day moving average price is $5.83 and its two-hundred day moving average price is $7.12. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.47 and a current ratio of 0.47.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on ABL shares. Piper Sandler dropped their price target on Abacus Life from $12.00 to $10.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 2nd. Maxim Group started coverage on Abacus Life in a research note on Tuesday, April 29th. They issued a "buy" rating and a $14.00 price objective on the stock. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $13.75.
Check Out Our Latest Stock Analysis on ABL
Institutional Trading of Abacus Life
A hedge fund recently raised its stake in Abacus Life stock. Bison Wealth LLC grew its position in Abacus Life, Inc. (NASDAQ:ABL - Free Report) by 492.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 61,125 shares of the company's stock after buying an additional 50,800 shares during the period. Bison Wealth LLC owned 0.06% of Abacus Life worth $479,000 at the end of the most recent reporting period.
Abacus Life Company Profile
(
Get Free Report)
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Recommended Stories
Before you consider Abacus Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abacus Life wasn't on the list.
While Abacus Life currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
